FR2581456B1 - Villine humaine, en tant que marqueur de cellules malignes primaires originaires du tube digestif, et moyens, en particulier anticorps diriges contre la villine humaine, pour la detection desdites cellules malignes - Google Patents

Villine humaine, en tant que marqueur de cellules malignes primaires originaires du tube digestif, et moyens, en particulier anticorps diriges contre la villine humaine, pour la detection desdites cellules malignes

Info

Publication number
FR2581456B1
FR2581456B1 FR8506707A FR8506707A FR2581456B1 FR 2581456 B1 FR2581456 B1 FR 2581456B1 FR 8506707 A FR8506707 A FR 8506707A FR 8506707 A FR8506707 A FR 8506707A FR 2581456 B1 FR2581456 B1 FR 2581456B1
Authority
FR
France
Prior art keywords
villine
malignant cells
human
marker
detection
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8506707A
Other languages
English (en)
Other versions
FR2581456A1 (fr
Inventor
Daniel Louvard
Brigitte Dudouet
Sylvie Robine
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Institut Pasteur de Lille
Original Assignee
Institut Pasteur de Lille
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR8506707A priority Critical patent/FR2581456B1/fr
Application filed by Institut Pasteur de Lille filed Critical Institut Pasteur de Lille
Priority to DE3650641T priority patent/DE3650641T2/de
Priority to EP86400957A priority patent/EP0206849B1/fr
Priority to JP61502415A priority patent/JP2688481B2/ja
Priority to PCT/FR1986/000150 priority patent/WO1986006494A1/fr
Priority to AT86400957T priority patent/ATE95313T1/de
Priority to DE86400957T priority patent/DE3689084T2/de
Priority to EP92105747A priority patent/EP0502553B1/fr
Priority to AT92105747T priority patent/ATE156136T1/de
Publication of FR2581456A1 publication Critical patent/FR2581456A1/fr
Application granted granted Critical
Publication of FR2581456B1 publication Critical patent/FR2581456B1/fr
Priority to US07/662,992 priority patent/US5188967A/en
Priority to JP6290159A priority patent/JP2698326B2/ja
Priority to US08/422,613 priority patent/US5635389A/en
Priority to JP7290113A priority patent/JP2698337B2/ja
Priority to JP9145137A priority patent/JPH1066574A/ja
Priority to JP10225587A priority patent/JPH11123091A/ja
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4735—Villin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
    • C07K16/3046—Stomach, Intestines
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
FR8506707A 1985-05-02 1985-05-02 Villine humaine, en tant que marqueur de cellules malignes primaires originaires du tube digestif, et moyens, en particulier anticorps diriges contre la villine humaine, pour la detection desdites cellules malignes Expired FR2581456B1 (fr)

Priority Applications (15)

Application Number Priority Date Filing Date Title
FR8506707A FR2581456B1 (fr) 1985-05-02 1985-05-02 Villine humaine, en tant que marqueur de cellules malignes primaires originaires du tube digestif, et moyens, en particulier anticorps diriges contre la villine humaine, pour la detection desdites cellules malignes
AT92105747T ATE156136T1 (de) 1985-05-02 1986-04-30 Peptidfragment des menschlichen villins und antikörper dagegen
EP86400957A EP0206849B1 (fr) 1985-05-02 1986-04-30 Moyens pour le diagnostic in vitro de cellules malignes originaires du tube digestif
JP61502415A JP2688481B2 (ja) 1985-05-02 1986-04-30 消化管起源の悪性細胞のｉｎ ｖｉｔｒｏ検出方法
PCT/FR1986/000150 WO1986006494A1 (fr) 1985-05-02 1986-04-30 Moyens pour le diagnostic in vitro de cellules malignesorigi naires du tube digestif
AT86400957T ATE95313T1 (de) 1985-05-02 1986-04-30 Verfahren zur in vitro-diagnose von boesartigen zellen aus dem verdauungstrakt.
DE86400957T DE3689084T2 (de) 1985-05-02 1986-04-30 Verfahren zur in vitro-Diagnose von bösartigen Zellen aus dem Verdauungstrakt.
EP92105747A EP0502553B1 (fr) 1985-05-02 1986-04-30 Fragment peptidique de la villine humaine et anticorps la reconnaissant
DE3650641T DE3650641T2 (de) 1985-05-02 1986-04-30 Peptidfragment des menschlichen Villins und Antikörper dagegen
US07/662,992 US5188967A (en) 1985-05-02 1991-02-28 Agents for the in vitro diagnosis of malignant cells originating in the digestive tract
JP6290159A JP2698326B2 (ja) 1985-05-02 1994-11-24 消化管起源の悪性細胞のｉｎ ｖｉｔｒｏ検出に使用し得る絨毛タンパク質をコードするＤＮＡの合成法
US08/422,613 US5635389A (en) 1985-05-02 1995-04-13 Antibodies which recognize and bind human villin
JP7290113A JP2698337B2 (ja) 1985-05-02 1995-11-08 消化管起源の悪性細胞のｉｎ ｖｉｔｒｏ検出に使用し得る抗絨毛モノクローナル抗体
JP9145137A JPH1066574A (ja) 1985-05-02 1997-06-03 消化管起源の悪性細胞のｉｎ ｖｉｔｒｏ検出に使用し得る抗絨毛タンパク質をコードするＤＮＡ
JP10225587A JPH11123091A (ja) 1985-05-02 1998-08-10 消化管起源の悪性細胞のｉｎ ｖｉｔｒｏ検出に使用し得るヒト絨毛タンパク質

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8506707A FR2581456B1 (fr) 1985-05-02 1985-05-02 Villine humaine, en tant que marqueur de cellules malignes primaires originaires du tube digestif, et moyens, en particulier anticorps diriges contre la villine humaine, pour la detection desdites cellules malignes

Publications (2)

Publication Number Publication Date
FR2581456A1 FR2581456A1 (fr) 1986-11-07
FR2581456B1 true FR2581456B1 (fr) 1987-07-17

Family

ID=9318907

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8506707A Expired FR2581456B1 (fr) 1985-05-02 1985-05-02 Villine humaine, en tant que marqueur de cellules malignes primaires originaires du tube digestif, et moyens, en particulier anticorps diriges contre la villine humaine, pour la detection desdites cellules malignes

Country Status (2)

Country Link
JP (1) JP2688481B2 (fr)
FR (1) FR2581456B1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2919060B1 (fr) 2007-07-19 2012-11-30 Biomerieux Sa Procede de dosage de l'ezrine pour le diagnostic in vitro du cancer colorectal.
ES2565512T3 (es) 2007-07-19 2016-04-05 bioMérieux Procedimiento de ensayo de la proteína de unión a ácidos grasos del hígado, de ACE y de CA19-9 para el diagnóstico in vitro del cáncer colorrectal
FR2919064B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine all pour le diagnostic in vitro du cancer colorectal
FR2919062B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'aminoacylase 1 pour le diagnostic in vitro du cancer colorectal.
FR2919063B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage du leucocyte elastase inhibitor pour le diagnostic in vitro du cancer colorectal.
FR2919065B1 (fr) 2007-07-19 2009-10-02 Biomerieux Sa Procede de dosage de l'apolipoproteine ai pour le diagnostic in vitro du cancer colorectal
FR2933773B1 (fr) 2008-07-10 2013-02-15 Biomerieux Sa Procede de dosage de la proteine disulfide isomerase pour le diagnostic in vitro du cancer colorectal

Also Published As

Publication number Publication date
JPS62502687A (ja) 1987-10-15
JP2688481B2 (ja) 1997-12-10
FR2581456A1 (fr) 1986-11-07

Similar Documents

Publication Publication Date Title
GB2180760B (en) Self-actuating breast lesion probe & method
NO163986C (no) Fremgangsmaate for in vitro bedoemmelse av muligheten for cellekreft.
IT8122136A0 (it) Capsule contenenti un allergene eprocedimento per la loro preparazione.
ZA854312B (en) Ultrasonic nondestructive tubing inspection system
GB8619848D0 (en) Inspection & sorting of containers
GB8402098D0 (en) Ultrasonic inspection of tube
JPS57179741A (en) Travelling body for inspecting pipeline
IT1200382B (it) Sistema di rilevazione e/o dosaggio di parametri clinici per via immuno enzimatica
NO894804D0 (no) Fremgangsmaate og celle for undersoekelse av boreproever vednedkjoeling.
IT8622618A0 (it) Preparato per la diagnosi della funzione di trasporto della salpinge e metodo per la sua preparazione.
FR2581456B1 (fr) Villine humaine, en tant que marqueur de cellules malignes primaires originaires du tube digestif, et moyens, en particulier anticorps diriges contre la villine humaine, pour la detection desdites cellules malignes
IT8621125A0 (it) Poli-4-aminopirrol-2-carbossamido derivati e procedimento per la loro preparazione.
IT8420739A1 (it) Aminoalchilen-eteri e -tioeteri benzenoidi biciclici e loro impieghi farmaceutici
AU6622586A (en) Method of assaying the presence of cancer cells
AU585913B2 (en) Pipeline inspection
ES523622A0 (es) Un metodo de deteccion de una sustancia de union especifica multivalente en un humor biologico.
NO851452L (no) Fremgangsmaate og cellelinje for fremstilling av plasminogene aktivatorer.
AU574430B2 (en) Measuring stress concentration utilizing ultrasound
AU1628183A (en) Suture inspection and gauging system
IT1171361B (it) Amminociclopentanon-ammidi e procedimento per la loro preparazione e formulazione farmaceutica
ES541436A0 (es) Procedimiento para preparar un agente farmaceutico que con- tiene un inhibidor de la enzima convertidora de angiotensina
AU4518889A (en) Method for the detection of multiple drug resistant tumor cells and verapamil probes useful therein
FR2544080B1 (fr) Procede de detection et de mesure par fluorescence d'une endocytose cellulaire dependante de proteines de la membrane cellulaire
IT8321792A0 (it) L'avanzamento di tratte e gallerie. procedimento e dispositivo per
IT1142102B (it) Derivati dell'imidazolo, procedimento per la loro preparazione, e composizione farmaceutica che li contiene

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse